Market Analysis

All Reports

Browse our comprehensive collection of market intelligence reports.

Healthcare|March 2020

West Nile Virus Infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

West Nile Virus Infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.West Nile Virus Infections Pipeline Analysis report covers drugs of 7 companies currently in different phases of development. West Nile Virus Infections are caused by the mosquito bites and are transmitted to people via virus. These infections are capable of causing a fatal

Healthcare|March 2020

Uveal (Ocular) Melanoma Pipeline Analysis 2019 (H1)

Uveal (Ocular) Melanoma Pipeline Analysis report covers 8 drugs currently in different phases of development. Uveal melanoma develops from the melanocyte cells in the eyes which are found in the uveal tract comprised of choroid, ciliary body and iris. The cause of the disease is yet not known, however it is more prevalent in Caucasians. The symptoms includes blurred vision, flashing lights or or a shadow in the eye. Treatment o

Healthcare|March 2020

Spinocerebellar Ataxia (SCA) Pipeline Analysis 2019 (H1)

Spinocerebellar Ataxia (SCA) Pipeline Analysis report covers approximately 10 drugs currently in different phases of development. Spinocerebellar Ataxia (SCA) is a term referring to the group of genetic autosomal dominant diseases that causes degenerative changes in the cerebellum. Symptoms of the disease are an uncoordinated walk, decreased hand-t

Healthcare|March 2020

Sarcoidosis Pipeline Analysis 2019 (H1)

Sarcoidosis Pipeline Analysis report covers drugs of 9 companies currently in different phases of development. Sarcoidosis is a rare inflammatory condition or disease which results in the formation of granulomas and causes organ inflammation. The disease is caused due to the body’s immune system responding to the foreign substances and they usually affect skin and lungs. Symptoms include red bumps on the skin, persistent cough and shortness of breath. As granulomas build up in the

Healthcare|March 2020

Neisseria Meningitidis Infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

<div id="tabs" class="ui-tabs ui-widget ui-widget-content ui-corner-all" style="box-sizing: border-box; background-image: initial !important; background-position: initial !important; background-size: initial !important; background-repeat: initial !important; background-attachment: initial !important; background-origin: initial !important; background-clip: initial !important; background-color: rgb(252, 252, 252); border: none !important; color: rgb(0, 0, 0); font-family: HelveticaNeue, &qu

Healthcare|March 2020

Myelofibrosis (MF) Pipeline Analysis 2019 (H1)

Myelofibrosis Pipeline Analysis report 2019 (H1) covers more than 10 drugs currently in different phases of development. Myelofibrosis is a chronic serious disorder which disrupts the normal production of the blood cells due to the excessive scarring in the bone marrow and belongs to a group of diseases called myeloproliferative disorders. The exac

Healthcare|March 2020

Myelodysplastic Syndrome (MDS) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Myelodysplastic Syndromes (MDS) are conditions that can occur when the blood cells in the bone marrow become abnormal. It is considered as a type of cancer. Myelodysplastic syndromes affect hematopoiesis at the stem cell level, as indicated by cytogenetic abnormalities, molecular mutations, and morphologic and physiologic abnormalities in mutation and differentiation of one or more of the hematopoietic cell lines.&nbsp; The dysplastic cells in the bone marrow have

Healthcare|March 2020

Myasthenia Gravis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Myasthenia Gravis Pipeline Analysis report covers 17 drugs currently in different phases of development. Myasthenia gravis (MG) is a neuromuscular disorder caused by impaired communication between nerves and muscles leading to the weakness and fatigue of the skeletal muscles. Symptoms of MG include slurred anf troubled speech, problems walking and lifting of objects, facial paralysis, difficulty in breathing, swallowing and chewing, extreme fatigue and double vision. It h

Healthcare|March 2020

Hypoparathyroidism Pipeline Analysis 2019 (H1)

Hypoparathyroidism Pipeline Analysis report covers 5 drugs currently in different phases of development. Hypoparathyroidism is a rare condition that arises due to inadequate production, secretion, and activity of the parathyroid hormone. The decreased level of parathyroid hormone leads to low calcium levels as well as low potassium levels in the bl

Healthcare|March 2020

Congenital Afibrinogenemia Pipeline Analysis 2019 (H1)

Congenital afibrinogenemia Pipeline Analysis report covers drugs of 2 companies currently in different phases of development. Congenital afibrinogenemia is an autosomal recessive blood coagulation disorder which is caused by mutations in one of the three genes; FGA, FGB, or FGG. Each of these genes is responsible for making a subunit of a protein (

Healthcare|March 2020

Clostridium Difficile infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Clostridium Difficile infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Clostridium Difficile infections Pipeline Analysis report covers drugs of 37 companies currently in different phases of development. Clostridium Difficile infections are caused by a bacterium, Clostridium difficile which causes diarrho

Healthcare|March 2020

Choroideremia Pipeline Analysis 2019 (H1)

Choroideremia Pipeline Analysis report covers 5 drugs currently in different phases of development. Choroideremia is a rare inherited disorder characterized by progressive vision loss due to degeneration of the choriocapillaris, retinal pigment epithelium, and the photoreceptor of the eye. Symptoms of the disease are night-blindness, vision loss in